Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - CAPITAL EXPENDITURES
Capital Expenditures GERN - Geron Corporation
-830 K
LAST VALUE
-100.24%
2 YEAR CAGR
-120.29%
5 YEAR CAGR
-75.47%
10 YEAR CAGR